Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors

A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as FMS inhibitors. A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as inhibitors of the kinase domain of macrophage colony-stimulating factor-1 receptor (FMS). The fully optimized compound, 4-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2008-03, Vol.18 (6), p.2097-2102
Hauptverfasser: Wall, Mark J., Chen, Jinsheng, Meegalla, Sanath, Ballentine, Shelley K., Wilson, Kenneth J., DesJarlais, Renee L., Schubert, Carsten, Chaikin, Margery A., Crysler, Carl, Petrounia, Ioanna P., Donatelli, Robert R., Yurkow, Edward J., Boczon, Lisa, Mazzulla, Marie, Player, Mark R., Patch, Raymond J., Manthey, Carl L., Molloy, Christopher, Tomczuk, Bruce, Illig, Carl R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as FMS inhibitors. A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as inhibitors of the kinase domain of macrophage colony-stimulating factor-1 receptor (FMS). The fully optimized compound, 4-(4-ethyl-phenyl)-3-(2-methyl-3 H-imidazol-4-yl)-2-quinolone-6-carbonitrile 21b, has an IC 50 of 2.5 nM in an in vitro assay and 5.0 nM in a bone marrow-derived macrophage cellular assay. Inhibition of FMS signaling in vivo was also demonstrated in a mouse pharmacodynamic model.
ISSN:0960-894X
0968-0896
1464-3405
1464-3391
DOI:10.1016/j.bmcl.2008.01.088